СПИСОК ЛИТЕРАТУРЫ

1. Jungwirth A, Diemer T, Kopa Z. Male Infertility. EAU guidelines. 2016.

2. Чалый МЕ, Ахвледиани НД, Харчилава РР. Мужское бесплодие. Российские клинические рекомендации. Урология. 2016; (1):2 - 16.

3. World Health Organization. WHO laboratory manual for the examination and processing of human semen - 5th ed. 2010. 287 p.

4. Баранов ВС, Кузнецова ТВ. Цитогенетика эмбрионального развития человека: Научно-практические аспекты. Издательст. СПб; 2006. 640 p.

5. Гинтер ЕК ПВ. Наследственные болезни. Национальное руководство. Краткое издание. ГЭОТАР-Мед. Москва; 2017. 464 p.

6. Strandell A, Lindhard A, Eckerlund I. Cost-effectiveness analysis of salpingectomy prior to IVF, based on a randomized controlled trial. Hum Reprod [Internet]. 2005; 20(12):3284-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16096324.

7. Noventa M, Gizzo S, Saccardi C, Borgato S, Vitagliano A, Quaranta M, et al. Salpingectomy before assisted reproductive technologies: a systematic literature review. J Ovarian Res [Internet]. 2016; 9(1):74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27809927.

8. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril [Internet]. 2012; 97(1):28-38.e25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22153789.

9. Адамян ЛВ, Андреева ЕН, Аполихина ИА, Беженарь ВФ, Геворкян МА, Гус АИ, et al. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации МЗ РФ. Москва; 2013. 89 p.

10. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014 Mar; 29(3):400-12.

11. Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, et al. Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology [Internet]. 2010; 256(3):943-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20505067.

12. Einarsson S, Bergh C, Friberg B, Pinborg A, Klajnbard A, P-O, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod. 2017; 32(8):1621-30.

13. Mushtaq R, Pundir J, Achilli C, Naji O, Khalaf Y, El-Toukhy T. Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018; 36(4):459-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29452915.

14. O'Flynn N. Assessment and treatment for people with fertility problems: NICE guideline. Br J Gen Pract [Internet]. 2014; 64 (618):50-1. Available from: http://bjgp.org/lookup/doi/10.3399/bjgp14X676609.

15. van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F, et al. Recombinant versus urinary gonadotrophm for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update [Internet]. 18(2):111. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22301671.

16. Weigert M, Krischker U, M, Poschalko G, Kindermann C, Feichtinger W. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertil Steril [Internet]. 2002; 78(1):34-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12095487.

17. Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online [Internet]. 2014; 29(6):684-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444501.

18. Gupta S, Satwik R, Majumdar A, Mittal S, Tiwari N. Clomiphene based ovarian stimulation in a commercial donor program. J Hum Reprod Sci [Internet]. 8(3):142-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26538856.

19. Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane database Syst Rev. 2012; 11:CD008528.

20. Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane database Syst Rev. 2017; 5:CD005070.

21. Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, K, et al. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril [Internet]. 2018; 109(4):644-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29653717.

22. Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BWJ, Marjoribanks J, et al. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane database Syst Rev. 2018; 2:CD012693.

23. Вспомогательные репродуктивные технологии (ВРТ). Рекомендации для врачей. 2007. 60 p.

24. Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane database Syst Rev. 2016; 4:CD001750.

25. Tang H, Mourad S, Zhai S-D, Hart RJ. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane database Syst Rev. 2016; 11:CD008605.

26. Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017; 23(5):560-79.

27. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril [Internet]. 2016; 106(7):1634-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27678032.

28. Wang R, Lin S, Wang Y, Qian W, Zhou L. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis. PLoS One [Internet]. 2017; 12(4):e0175985. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28437434.

29. Youssef MAFM, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane database Syst Rev. 2014; (10):CD008046.

30. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective rando. Fertil Steril [Internet]. 2008; 89(1):84-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17462639.

31. Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online [Internet]. 2009; 19(4):486-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19909588.

32. Улезко-Строгонова КП. Къ вопросу о тончайшемъ строении децидуальной ткани, ее гистогенезъ, значенiи месте развития въ половомъ аппарате женщины. Ж Акушерства и женскихъ болезней. 1908; (7, 8).

33. Никитин АИ. Комментарий к статье В.С. Корсака "К вопросу о роли эндометрия в имплантации эмбрионов". Проблемы репродукции. 2016; 22(3): 127-8.

34. Kasius A, Smit JG, Torrance HL, Eijkemans MJC, Mol BW, Opmeer ВС, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 20(4):530-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24664156.

35. Check JH, Cohen R. Live fetus following embryo transfer in a woman with diminished egg reserve whose maximal endometrial thickness was less than 4 mm. Clin Exp Obstet Gynecol [Internet]. 2011; 38(4):330-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22268267.

36. Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol [Internet]. 2013; 11:35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23663223.

37. Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet [Internet]. 2012; 29(11):1227-39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22976427.

38. Chen S-L, Wu F-R, Luo C, Chen X, Shi X-Y, Zheng H-Y, et al. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study. Reprod Biol Endocrinol [Internet]. 2010; 8:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20334664.

39. Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod [Internet]. 2010; 25(10):2496-500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20729538.

40. Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane database Syst Rev [Internet]. 2010; (1):CD000099. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20091500.

41. Farquhar C, Rombauts L, Kremer JA, Lethaby A, Ayeleke RO. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane database Syst Rev. 2017; 5:CD006109.

42. Chang FE, Beall SA, Cox JM, Richter KS, DeCherney AH, Levy MJ. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response. Fertil Steril [Internet]. 2016; 106(5):1093-1100.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27341988.

43. Garcia-Velasco JA, Fatemi HM. To pill or not to pill in GnRH antagonist cycles: that is the question! Reprod Biomed Online [Internet]. 2015; 30(1):39-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25447926.

44. Reichman DE, Chung P, Meyer L, Greenwood E, Davis O, Rosenwaks Z. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes? Fertil Steril [Internet]. 2013 Apr; 99(5): 1277-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23290740.

45. Caligara C, Navarro J, Vargas G, C, Pellicer A, J. The effect of repeated controlled ovarian stimulation in donors. Hum Reprod [Internet]. 2001 Nov; 16(11):2320-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11679512.

46. Higgins C, Healey M, Jatkar S, Vollenhoven B. Interval between IVF stimulation cycle and frozen embryo transfer: Is there a benefit to a delay between cycles? Aust N Z J Obstet Gynaecol [Internet]. 2018 Apr; 58(2):217-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28905357.

47. Wikland M, Blad S, Bungum L, Hillensjo T, Karlstrom PO, Nilsson S. A randomized controlled study comparing pain experience between a newly designed needle with a thin tip and a standard needle for oocyte aspiration. Hum Reprod [Internet]. 2011; 26(6):1377-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21467200.

48. Weiss A, Neril R, Geslevich J, Lavee M, Beck-Fruchter R, Golan J, et al. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study. Fertil Steril [Internet]. 2014; 102(2):419-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24880653.

49. Nargund G, Reid F, Parsons J. Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study. J Assist Reprod Genet [Internet]. 2001; 18(2):87-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11285986.

50. Bjercke S, Tanbo T, Dale PO, Abyholm T. Comparison between two hCG-to-oocyte aspiration intervals on the outcome of in vitro fertilization. J Assist Reprod Genet [Internet]. 2000; 17(6):319-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11042828.

51. Mansour RT, Aboulghar MA, Serour GI. Study of the optimum time for human chorionic gonadotropin-ovum pickup interval in in vitro fertilization. J Assist Reprod Genet [Internet]. 1994; 11(9):478-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7633170.

52. Wang W, Zhang X-H, Wang W-H, Liu Y-L, Zhao L-H, Xue S-L, et al. The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis. J Assist Reprod Genet [Internet]. 2011; 28(10):901-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792666.

53. Levy G, Hill MJ, Ramirez CI, Correa L, Ryan ME, DeCherney AH, et al. The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis. Hum Reprod [Internet]. 2012; 27(8):2373-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22647450.

54. Farquhar C, Rishworth JR, Brown J, Nelen WLDM, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane database Syst Rev [Internet]. 2015; (7):CD010537. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26174592.

55. Glujovsky D, Farquhar C, Quinteiro Retamar AM, Alvarez Sedo CR, Blake D. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane database Syst Rev. 2016; (6):CD002118.

56. Phillips SJ, Dean NL, Buckett WM, Tan SL. Consecutive transfer of day 3 embryos and of day 5 - 6 blastocysts increases overall pregnancy rates associated with blastocyst culture. J Assist Reprod Genet [Internet]. 2003; 20(11):461-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14714825.

57. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Performing the embryo transfer: a guideline. Fertil Steril [Internet]. 2017; 107(4):882-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28366416.

58. Brown J, Buckingham K, Buckett W, Abou-Setta AM. Ultrasound versus "clinical touch" for catheter guidance during embryo transfer in women. Cochrane database Syst Rev. 2016; 3:CD006107.

59. Buckett WM. A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer. Fertil Steril [Internet]. 2006; 85(3):728-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16500345.

60. Sroga JM, Montville CP, Aubuchon M, Williams DB, Thomas MA. Effect of delayed versus immediate embryo transfer catheter removal on pregnancy outcomes during fresh cycles. Fertil Steril [Internet]. 2010; 93(6):2088-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20116786.

61. Tiras B, Polat M, Korucuoglu U, Zeyneloglu HB, Yarali H. Impact of embryo replacement depth on in vitro fertilization and embryo transfer outcomes. Fertil Steril [Internet]. 2010; 94(4):1341-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20044085.

62. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane database Syst Rev. 2014; (2):CD007421.

63. Craciunas L, Tsampras N, Fitzgerald C. Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014; 101(5):1302-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24602754.

64. Oraif A, Hollet-Caines J, Feyles V, Rebel M, Abduljabar H. Do multiple attempts at embryo transfer affect clinical pregnancy rates? J Obstet Gynaecol Can. 2014; 36(5):406-7.

65. Kroon B, Hart RJ, Wong BMS, Ford E, Yazdani A. Antibiotics prior to embryo transfer in ART. Cochrane database Syst Rev [Internet]. 2012; (3):CD008995. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22419341.

66. van der Ven H, Diedrich K, Al-Hasani S, Pless V, Krebs D. The effect of general anaesthesia on the success of embryo transfer following human in-vitro fertilization. Hum Reprod [Internet]. 1988; 3 Suppl 2:81-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068244.

67. European IVF-monitoring Consortium (EIM), European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017; 32(10):1957-73.

68. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the Society for Assisted Reproductive Technology. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil Steril [Internet]. 2017; 107(4):901-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28292618.

69. Mancuso AC, Boulet SL, Duran E, Munch E, Kissin DM, Van Voorhis BJ. Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics. Fertil Steril. 2016 Oct; 106(5):1107-14.

70. Kissin DM, Kulkarni AD, Mneimneh A, Warner L, Boulet SL, Crawford S, et al. Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention. Fertil Steril [Internet]. 2015; 103(4):954-61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25637480.

71. Richter KS, Ginsburg DK, Shipley SK, Lim J, Tucker MJ, Graham JR, et al. Factors associated with birth outcomes from cryopreserved blastocysts: experience from 4,597 autologous transfers of 7,597 cryopreserved blastocysts. Fertil Steril [Internet]. 2016; 106(2):354-362.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27172399.

72. Chen X, Liu P, Sheng Y, Li W, Tang R, Ding L, et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: a matched retrospective cohort study. J Matern Fetal Neonatal Med [Internet]. 2018; 1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29649918.

73. JOINT SOGC-CFAS. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006. Int J Gynaecol Obstet. 2008; 102(2):203-16.

74. Prevention of twin pregnancies after IVF/ICSI by single embryo transfer. ESHRE Campus Course Report. Hum Reprod [Internet]. 2001; 16(4):790-800. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11278236.

75. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril [Internet]. 1994; 61(6):1068-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8194619.

76. Connell MT, Szatkowski JM, Terry N, DeCherney AH, Propst AM, Hill MJ. Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril [Internet]. 2015; 103(4):939-946.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25638420.

77. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane database Syst Rev. 2015; (7):CD009154.

78. Child T, Leonard SA, Evans JS, Lass A. Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles. Reprod Biomed Online [Internet]. 2018; 36(6):630-45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29550390.

79. Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod [Internet]. 2014; 29(8):1706-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24847018.

80. Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod [Internet]. 2017; 32(10):2152. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28938733.

81. Применение эстрогенов в программах ВРТ. Научно-практические рекомендации. РАРЧ. 2015.

82. Корсак ВС, Каменецкий БА, Михайлов АВ. Значимость толщины и ультразвуковой структуры эндометрия в программе ЭКО. Проблемы репродукции. 2001; 7(3):36-9.

83. Aydin T, Kara M, Nurettin T. Relationship between Endometrial Thickness and In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome. Int J Fertil Steril [Internet]. 2013; 7(1):29-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24520460.

84. Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol [Internet]. 2008; 6:37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940.

85. Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod Med [Internet]. 2012; 58(2):107-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22206474.

86. Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC Womens Health [Internet]. 2012; 12:27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22950651.

87. Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol [Internet]. 2014; 7(10):6992-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25400786.

88. Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014; 10(1):161-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229.

89. Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet [Internet]. 2000; 17(1):28-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754780.

90. Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004; 81(1):1-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532.

91. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2015 г. Проблемы репродукции. 2017; 23(5):8-22.

92. Корнеева ЕИ. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013.

93. Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol Metab [Internet]. 2015; 100(12):4396-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26513003.

94. Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014; 101(3):664-75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566.

95. Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol [Internet]. 2015; 13:66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393.

96. Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014; 29(5):545-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236.

97. Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol [Internet]. 2015; 13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617.

98. Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358.

99. Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril [Internet]. 1996; 65(6):1093-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479.

100. Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet]. 2014; 102(4):1203-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389.

101. Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet]. 2014; 93(5):483-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701.

102. Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum Reprod [Internet]. 2000; 15(9):1943-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10966991.

103. Nazari A, Askari HA, Check JH, O'Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993; 60(5):919-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280.

104. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013; (7):CD003416.

105. Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009; 23(5):691-709. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900.

106. S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018; 89(1):1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339.

107. Bodri D, JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online [Internet]. 2008; 17(2):237-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18681998.

108. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of > 1000 oocyte retrievals. Hum Reprod [Internet]. 2006; 21(12):3235-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373.

109. Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East Fert Soc J. 2007; 12(1):N1.

110. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998; 70(4):638-42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090.

111. Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet]. 2(4):345-53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231.

112. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol [Internet]. 1998; 77(2):239-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285.

113. Кулаков ВИ, Леонов БВ. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p.

114. Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet]. 1990; 53(1):76-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348.

115. Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017; 34(5):627-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550.

116. Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol [Internet]. 1990; 76(3 Pt l):403-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611.

117. Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003; 32(6):535-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299.

118. Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion. Radiographics [Internet]. 28(5):1355-68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794312.

119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod Biol [Internet]. 2010; 150(1):8-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20189289.

120. Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet]. 2011; 30(9):1205-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091.

121. Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum Reprod Update [Internet]. 6(5):432-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11045874.

122. Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, MS Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017; 32(10):1957-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842.

123. Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive Technologies: A Systematic Review. J Pathog [Internet]. 2016; 2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692.

124. Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008; 5(1):194-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085.

125. Ohl DA, Quallich SA, J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008; 35(2):211--20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241.

126. Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol [Internet]. 2010; 183(6):2304-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20400139.

127. Ohl DA, Quallich SA, J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach. Semin Reprod Med [Internet]. 2009; 27(2):179-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920.

128. Brackett NL, Lynne CM, Ibrahim E, Ohl DA, J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010; 7(3):162-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304.

129. Корнеев ИА, Зассеев РД. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017; 7(2):10-5.

130. Colpi GM, Piediferro G, Nerva F, Giacchetta D, Colpi EM, Piatti E. Sperm retrieval for intra-cytoplasmic sperm injection in non-obstructive azoospermia. Minerva Urol Nefrol [Internet]. 2005; 57(2):99-107. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15951734.

131. Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology [Internet]. 2014; 2(1):20-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24193894.

132. Krausz C, Degl'Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci [Internet]. 2006; 11:3049-61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720375.

133. Ghanem M, Bakr NI, Elgayaar MA, El Mongy S, Fathy H, Ibrahim A-HA. Comparison of the outcome of intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia in the first cycle: a report of case series and metaanalysis. Int J Androl [Internet]. 2005; 28(1):16 - 21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15679616.

134. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P. Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril [Internet]. 2003; 79(3):529-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12620435.

135. Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod [Internet]. 2015; 30(8):1790-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26082482.

136. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol [Internet]. 2013; 168(4):R67-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504510.

137. Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that's the question. Fertil Steril [Internet]. 2012; 98(2):284-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608314.

138. Kastrop PM, Weima SM, Van Kooij RJ, Te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod [Internet]. 1999; 14(1):65-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10374096.

139. Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A. Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia. Hum Reprod [Internet]. 1999; 14(9):2313-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10469701.

140. Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD. Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum Reprod [Internet]. 1994; 9(11):2051-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7868673.

141. Plachot M, Belaisch-Allart J, Mayenga J-M, Chouraqui A, Tesquier L, Serkine AM. Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility. Hum Reprod [Internet]. 2002; 17(2):362-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11821279.

142. Henkel RR, Schill W-B. Sperm preparation for ART. Reprod Biol Endocrinol [Internet]. 2003; 1:108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14617368.

143. Beydola T, Sharma RK, Agarwal A. Sperm preparation and selection techniques. Med Surg Manag male Infertil. 2014; (29):244-51.

144. on Good EGG. Revised guidelines for good practice in IVF laboratories (2015): Guideline of the European Society of Human Reproduction and Embryology.

145. Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane database Syst Rev. 2013; (4):CD009391.

146. Kazem R, Thompson LA, Srikantharajah A, Laing MA, Hamilton MP, Templeton A. Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod [Internet]. 1995; 10(10):2650-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8567786.

147. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update [Internet]. 13(6):591-605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17846105.

148. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD Consortium/Embryology Special Interest Group-best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod [Internet]. 2011; 26(1):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20966459.

149. Thornhill AR, DeDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al. ESHRE PGD Consortium "Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)". Hum Reprod [Internet]. 2005; 20(1):35-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15539444.

150. ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update [Internet]. 13(6):515-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17630396.

151. Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril [Internet]. 2012; 98(6): 1395-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981171.

152. van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril [Internet]. 2005; 83(3):612-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15749489.

153. Kinzer DR, Barrett CB, Powers RD. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril [Internet]. 2008; 90(2):284-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17714711.

154. Johnson LNC, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril [Internet]. 2013; 100(3):704-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23773312.

155. Moreno C, Ruiz A, C, Pellicer A, J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod [Internet]. 1998; 13(8):2126-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9756282.

156. Luna M, Bigelow C, Duke M, Ruman J, Sandler B, Granfeld L, et al. Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved? J Assist Reprod Genet [Internet]. 2011; 28(10):911-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21792665.

157. Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril [Internet]. 2007; 88(3):622-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445809.

158. Hwang JL, Lin YH, Tsai YL. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet [Internet]. 2000; 17(1):39-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10754782.

159. Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, Van Steirteghem A. Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. Fertil Steril [Internet]. 1996; 65(5):1047-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8612833.

160. Tucker M, Graham J, Han T, Stillman R, Levy M. Conventional insemination versus intracytoplasmic sperm injection. Lancet (London, England) [Internet]. 2001; 358(9293):1645-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11716920.

161. Teixeira DM, Barbosa MAP, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al. Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane database Syst Rev. 2013; (7):CD010167.

162. McDowell S, Kroon B, Ford E, Hook Y, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane database Syst Rev. 2014; (10):CD010461.

163. Cohen J, Alikani M, Trowbridge J, Rosenwaks Z. Implantation enhancement by selective assisted hatching using zona drilling of human embryos with poor prognosis. Hum Reprod [Internet]. 1992; 7(5):685-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1639990.

164. Zeng M, Su S, Li L. The effect of laser-assisted hatching on pregnancy outcomes of cryopreserved-thawed embryo transfer: a meta-analysis of randomized controlled trials. Lasers Med Sci [Internet]. 2018; 33(3):655-66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29116610.

165. Carney S-K, Das S, Blake D, Farquhar C, Seif MMW, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). Cochrane database Syst Rev. 2012; 12:CD001894.

166. Capalbo A, Romanelli V, Cimadomo D, Girardi L, Stoppa M, Dovere L, et al. Implementing PGD/PGD-A in IVF clinics: considerations for the best laboratory approach and management. J Assist Reprod Genet [Internet]. 2016; 33(10):1279-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27423665.

167. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update [Internet]. 17(4):438-53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21474527.

168. Li D, Yang D-L, An J, Jiao J, Zhou Y-M, Wu Q-J, et al. Effect of assisted hatching on pregnancy outcomes: a systematic review and meta-analysis of randomized controlled trials. Sci Rep [Internet]. 2016; 6:31228. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503701.

169. Goossens V, De Rycke M, De Vos A, Staessen C, Michiels A, Verpoest W, et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 2008; 23(3):481-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18156649.

170. De Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P, et al. Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod [Internet]. 2009; 24(12):2988-96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19773223.

171. Dumoulin JC, Bras M, Coonen E, Dreesen J, Geraedts JP, Evers JL. Effect of Ca2+/Mg2+-free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod [Internet]. 1998; 13(10):2880-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9804249.

172. Kahraman S, M, Samli H, N, Yakisn K, Cengiz G, et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod [Internet]. 2000; 15(9):2003-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10967004.

173. S, Cohen J. Unsuitability of multinucleated human blastomeres for preimplantation genetic diagnosis. Hum Reprod [Internet]. 1993; 8(7):1120-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8408497.

174. Geber S, Bossi R, Lisboa CB, Valle M, Sampaio M. Laser confers less embryo exposure than acid tyrode for embryo biopsy in preimplantation genetic diagnosis cycles: a randomized study. Reprod Biol Endocrinol [Internet]. 2011; 9:58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21527004.

175. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obs Gynecol. 1999; 13(3):307-11.

176. Wininger JD, Taylor TH, Orris JJ, Glassner M, Anderson SH. Pregnancy after rebiopsy and vitrification of blastocysts following allele dropout after day 3 biopsy. Fertil Steril [Internet]. 2011; 95(3):1122.e1-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20951376.

177. Greco E, Biricik A, Cotarelo RP, Iammarone E, Rubino P, Tesarik J, et al. Successful implantation and live birth of a healthy boy after triple biopsy and double vitrification of oocyte-embryo-blastocyst. Springerplus [Internet]. 2015; 4:22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25625041.

178. Eldar-Geva T, Srebnik N, Altarescu G, Varshaver I, Brooks B, Levy-Lahad E, et al. Neonatal outcome after preimplantation genetic diagnosis. Fertil Steril [Internet]. 2014; 102(4):1016-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25064409.

179. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn [Internet]. 2001; 21(9):767-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11559914.

180. Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017; 23(2):139-55.

181. Cobo A, Meseguer M, J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010; 25(9):2239-46.

182. Cobo A, Garrido N, Pellicer A, J. Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril [Internet]. 2015; 104(6):1426-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26353081.

183. Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018; 24(1):35-58.

184. Shi Q, Xie Y, Wang Y, Li S. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis. Sci Rep [Internet]. 2017; 7(1):8538. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28819292.

185. Zhou X-H, Zhang D, Shi J, Wu Y-J. Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles: A meta-analysis. Medicine (Baltimore) [Internet]. 2016; 95(39):e4095. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27684791.

186. Justice T, Christensen G. Sperm cryopreservation methods. Methods Mol Biol [Internet]. 2013; 927:209-15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22992915.

187. Levron J, Madgar I, Shefi S, Meirow D, Wiser A, Bider D, et al. IVF outcome with cryopreserved testicular sperm. Andrologia [Internet]. 2011; 43(1):48-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21219382.

188. Hovatta O, Foudila T, Siegberg R, Johansson K, von Smitten K, Reima I. Pregnancy resulting from intracytoplasmic injection of spermatozoa from a frozen-thawed testicular biopsy specimen. Hum Reprod [Internet]. 1996; 11(11):2472-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8981136.

189. Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human oocytes and embryos. Reprod Biomed Online [Internet]. 2015; 30(4):325-33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25639657.

190. Youm HS, Choi J-R, Oh D, Rho YH. Survival Rates in Closed and Open Vitrification for Human Mature Oocyte Cryopreservation: A Meta-Analysis. Gynecol Obstet Invest [Internet]. 2018; 83(3):268-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29131105.

191. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017; 108(3):393-406.

192. Гинтер ЕК, Пузырев ВП. Наследственные болезни. Национальное руководство. Краткое издание. ГЭОТАР-Мед. Москва; 2017. 464 p.

193. Daughtry BL, Chavez SL. Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences. Cell Tissue Res [Internet]. 2016; 363(1):201-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26590822.

194. Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016; 31(10):2245-54.

195. De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C. ESHRE PGD Consortium data collection XIV - XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod [Internet]. 2017; 32(10):1974-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29117384.

196. PGDIS position statement on chromosome mosaicism and preimplantation aneuploidy testing at the blastocyst stage. Chicago: PGDIS Newsletter, July 19, 2016.

197. Liss J, Chromik I, J, M, A, Lukaszuk K. Current methods for preimplantation genetic diagnosis. Ginekol Pol [Internet]. 2016; 87(7):522-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27504946.

198. Kane SC, Willats E, Bezerra Maia E Holanda Moura S, Hyett J, da Silva Costa F. Pre-Implantation Genetic Screening Techniques: Implications for Clinical Prenatal Diagnosis. Fetal Diagn Ther [Internet]. 2016; 40(4):241-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27682145.

199. Chen H-F, Chen S-U, Ma G-C, Hsieh S-T, Tsai H-D, Yang Y-S, et al. Preimplantation genetic diagnosis and screening: Current status and future challenges. J Formos Med Assoc [Internet]. 2018; 117(2):94-100. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28888353.

200. Lu L, Lv B, Huang K, Xue Z, Zhu X, Fan G. Recent advances in preimplantation genetic diagnosis and screening. J Assist Reprod Genet [Internet]. 2016; 33(9):1129-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27272212.

201. Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 2016 Jul; 33(7):823-32.

202. Рыжкова О, Кардымон О, Прохорчук Е. Руководство по интерпретации данных, полученных методами массового параллельного секвенирования (MPS). Медицинская генетика. 2017; 16(7):4-17.

203. Deglincerti A, Croft GF, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Self-organization of the in vitro attached human embryo. Nature [Internet]. 2016; 533(7602):251-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27144363.

204. Cardozo ER, Karmon AE, Gold J, Petrozza JC, Styer AK. Reproductive outcomes in oocyte donation cycles are associated with donor BMI. Hum Reprod [Internet]. 2016; 31(2):385-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26677960.

205. Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a committee opinion. Fertil Steril [Internet]. 2013; 99(1):47-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23095142.

206. Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced age: a committee opinion. Fertil Steril [Internet]. 2013; 100(2):337-0. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23472948.

207. Ethics Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion. Fertil Steril [Internet]. 2016; 106(5):e3-e7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27450186.

208. Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, et al. Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older. Hum Reprod [Internet]. 2012; 27(3):896-901. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22252087.

209. Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Recommendations for practices utilizing gestational carriers: a committee opinion. Fertil Steril [Internet]. 2017; 107(2):e3-e10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28069181.

210. Сельков СА, Ярмолинская МИ. Эндометриоз как патология регуляторных механизмов. Журнал акушерства и женских болезней. 2017; 66(2):9-13.

211. Schifrin BS, Erez S, Moore JG. Teen-age endometriosis. Am J Obstet Gynecol [Internet]. 1973; 116(7):973-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4718224.

212. Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med [Internet]. 1989; 34(1):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2704007.

213. Giudice LC, Kao LC. Endometriosis. Lancet (London, England) [Internet]. 364(9447):1789-99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15541453.

214. Fuentes A, Escalona J, P, Espinoza A, Johnson MC. [Prevalence of endometriosis in 287 women undergoing surgical sterilization in Santiago Chile]. Rev Med Chil [Internet]. 2014; 142(1): 16-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24861109.

215. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am [Internet]. 2012; 39(4):535-49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23182559.

216. Bondza PK, Maheux R, Akoum A. Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed) [Internet]. 2009; 1:415-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19482656.

217. Saito H, Seino T, Kaneko T, Nakahara K, Toya M, Kurachi H. Endometriosis and oocyte quality. Gynecol Obstet Invest [Internet]. 2002; 53 Suppl 1:46-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11834868.

218. Mansour G, Aziz N, Sharma R, Falcone T, Goldberg J, Agarwal A. The impact of peritoneal fluid from healthy women and from women with endometriosis on sperm DNA and its relationship to the sperm deformity index. Fertil Steril [Internet]. 2009; 92(1):61-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19409553.

219. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril [Internet]. 2010; 94(5):1894-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19896655.

220. Garrido N, Navarro J, J, Remoh J, Pellice A, C. The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update [Internet]. 8(1):95-103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11866246.

221. Kissler S, Zangos S, Wiegratz I, Kohl J, Rody A, Gaetje R, et al. Uterotubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci [Internet]. 2007; 1101:38-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17344532.

222. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril [Internet]. 2002; 77(6): 1148-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12057720.

223. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update [Internet]. 2(5):385-98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15717438.

224. S, R, Lousse J-C, Colette S, Donnez O, Donnez J, et al. Insights into iron and nuclear factor-kappa В (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol [Internet]. 2011; 26(8):1083-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21692040.

225. Lousse J-C, Van Langendonckt A, Defrere S, Ramos RG, Colette S, Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) [Internet]. 2012; 4:23-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22201853.

226. Duffy JMN, Arambage K, Correa FJS, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane database Syst Rev. 2014; (4):CD011031.

227. Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A, et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction [Internet]. 2009; 137(4):727-37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19129371.

228. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane database Syst Rev. 2004; (3):CD003678.

229. Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010 Oct; 94(5): 1609-15.

230. Zikopoulos К, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand [Internet]. 2004; 83(7):651-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15225190.

231. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril [Internet]. 2002; 78(4):757-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372452.

232. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane database Syst Rev [Internet]. 2006; (1):CD004635. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16437491.

233. Gong F, Tang Y, Zhang H, Lu G. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban [Internet]. 2009; 34(3):185-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19349670.

234. van der Houwen LEE, Mijatovic V, Leemhuis E, Schats R, Heymans MW, Lambalk CB, et al. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation. Reprod Biomed Online [Internet]. 2014; 28(1):39-46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24262434.

235. Giudice LC, Evers LH, Healy DL, editors. Endometriosis: science and practice. London: Wiley-Blackwell; 2012. 600 p.

236. Смольникова ВЮС. Изучение особенностей действия агонистов гонадотропин-рилизинг гормона - депо-декапептила и нафарелина в программе экстракорпорального оплодотворения и переноса эмбрионов в полость матки. Москва; 1995. 24 p.

237. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril [Internet]. 2002; 78(4):699-704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372443.

238. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod [Internet]. 2005; 20(10):2698-704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15980014.

239. Leung AS, Dahan MH. The benefits of other treatments than in vitro fertilization to aid conception in minimal and mild endometriosis. Minerva Ginecol [Internet]. 2016; 68(6):675-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27077394.

240. Boujenah J, Santulli P, Mathieu-d'Argent E, Decanter C, Chauffeur C, Poncelet P. [First line management without IVF of infertility related to endometriosis: Result of medical therapy? Results of ovarian superovulation? Results of intrauterine insemination? CNGOF-HAS Endometriosis Guidelines]. Gynecol Obstet Fertil Senol [Internet]. 2018; 46(3):331-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29551300.

241. Geisler ME, Ledwidge M, Bermingham M, McAuliffe M, McMenamin MB, Waterstone JJ. Intrauterine insemination-No more Mr. N.I.C.E. guy? Eur J Obstet Gynecol Reprod Biol [Internet]. 2017; 210:342-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28122315.

242. Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane database Syst Rev. 2015; (11):CD006919.

243. Bastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS J Soc Laparoendosc Surg [Internet]. 18(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/25392665.

244. Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I - II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril [Internet]. 2007; 88(4):832-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17428479.

245. Kitajima M, Khan KN, Harada A, Taniguchi K, Inoue T, Kaneuchi M, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed) [Internet]. 2018; 10:92-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930606.

246. Yanushpolsky EH, Best CL, Jackson KV, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet [Internet]. 1998; 15(4):193-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9565848.

247. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010 May; 93(7):2431-2.

248. Brosens I. Endometriosis and the outcome of in vitro fertilization. Fertil Steril [Internet]. 2004; 81(5):1198-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136075.

249. Geber S, Ferreira DP, Spyer Prates LFV, Sales L, Sampaio M. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed Online [Internet]. 5(2):162-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12419041.

250. Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014 Oct; 29(10):2190-8.

251. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab [Internet]. 2012; 97(9):3146-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22723324.

252. Garcia-Velasco JA, Mahutte NG, Corona J, V, J, Arid A, et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril [Internet]. 2004; 81(5):1194-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136074.

253. Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G. IVF-ICSI outcome in women operated on for bilateral endometriomas. Hum Reprod [Internet]. 2008; 23(7):1526-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18441346.

254. Ruiz Anguas J, Carballo E, Anta Jaen E, Monterrosas L, Kably Ambe A. [Clinical implication and frequency of the incidental finding of endometriosis during oocyte retrieval]. Ginecol Obstet Мех [Internet]. 2007; 75(3):121-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17547085.

255. Cirpan T, Akercan F, Tavmergen Goker EN, Ozyurek E, Levi R, Tavmergen E. Laparoscopic resection or sonography-guided vaginal aspiration of endometriomas prior to ICSI-ET does not worsen treatment outcomes. Clin Exp Obstet Gynecol [Internet]. 2007; 34(4):215-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18225681.

256. Demirol A, Guven S, Baykal C, Gurgan T. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reprod Biomed Online [Internet]. 2006; 12(5):639-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16790114.

257. Yu H-T, Huang H-Y, Tseng H-J, Wang C-J, Lee C-L, Soong Y-K. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy. Biomed J [Internet]. 2017; 40(5):295-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29179885.

258. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 21(6):809-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26168799.

259. Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol [Internet]. 2017; 209:81-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26968428.

260. Jadoul P, Kitajima M, Donnez O, Squifflet J, Donnez J. Surgical treatment of ovarian endometriomas: state of the art? Fertil Steril [Internet]. 2012; 98(3):556-63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22763094.

261. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril [Internet]. 2017; 108(3):483-490.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28865548.

262. Mavrelos D, Holland TK, O'Donovan O, Khalil M, Ploumpidis G, Jurkovic D, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod Biomed Online [Internet]. 2017; 35(5):549-54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28802706.

263. Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand [Internet]. 2017; 96(6):715-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28556124.

264. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014; 29(5):964-77.

265. Soave I, Wenger J-M, Pluchino N, Marci R. Treatment options and reproductive outcome for adenomyosis-associated infertility. Curr Med Res Opin [Internet]. 2018; 34(5):839-49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29046066.

266. Назаренко ТА. Стимуляция функции яичников. М.: МЕДпресс-информ; 2015. 288 p.

267. Wang B, Kong N, Liu J-Y, Zhang N-Y, Zhu Y-C, Zhou J-J. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy]. Zhonghua Nan Ke Xue [Internet]. 2017; 23(12):1099-102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29738181.

268. Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis. J Hum Reprod Sci [Internet]. 9(2):70-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27382230.

269. Youssef MA-F, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril [Internet]. 2018; 109(2):289-301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29317127.

270. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril [Internet]. 2015; 104(5):1145. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26297646.

271. Fan W, Li S, Chen Q, Huang Z, Ma Q, Wang Y. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol [Internet]. 2013; 29(4):278-84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347045.

272. Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol [Internet]. 2014; 12:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24555766.

273. Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017; 32(1):112-8.

274. Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol [Internet]. 2012; 10:114. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23249758.

275. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril [Internet]. 2018; 109(6):993-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29935660.

276. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012; 27(12):3481-6.

277. Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod [Internet]. 2013; 28(11):2981-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23887073.

278. Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, et al. Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis. Front Endocrinol (Lausanne) [Internet]. 2018; 9:317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29963011.

279. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of "Low prognosis patients in Assisted Reproductive Technology" and its proposed marker of successful outcome. F1000Research [Internet]. 2016; 5:2911. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28232864.

280. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. 2016; 105(6):1452-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26921622.

281. Cobo A, Garrido N, Crespo J, R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online [Internet]. 2012; 24(4):424-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22386762.

282. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013 Jul; 100(1):100-7.e1.

283. Galliano D, Bellver J, C, Simon C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update [Internet]. 21(1):13-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25155826.

284. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ [Internet]. 2000; 320(7230):279-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10650023.

285. Guida M, Pellicano M, Zullo F, Acunzo G, Lavitola G, Palomba S, et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod [Internet]. 2003; 18(4):840-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12660281.

286. Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril [Internet]. 2003; 79(2):418-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12568856.

287. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol [Internet]. 2012; 19(2):152-71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1553465011011897.

288. Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun J-L, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol [Internet]. 2012; 165(2):156-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22939241.

289. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol [Internet]. 2008; 198(4):357-66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18395031.

290. Коган ИЮ, Беженарь ВФ, Долинский АК, Чмаро МГ. Эффективность вспомогательных методов репродукции у больных с миомой матки. Журнал акушерства и женских болезней. 2012; (4):113-8.

291. Seki H, Takizawa Y, Sodemoto Т. Epidural analgesia for painful myomas refractory to medical therapy during pregnancy. Int J Gynaecol Obstet [Internet]. 2003; 83(3):303-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14643043.

292. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol [Internet]. 2012; 120(1):37-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678036.

293. Тапильскя НИ, Карпеев СА, Гайдуков СН. Обоснование эффективности антибактериальной терапии в лечении хронической воспалительной болезни матки. Вестник дерматологии и венерологии. 2015; (2):130-8.

294. Шуршалина, А.В. Клинико-морфологические особенности хронического эндометрита у женщин с нарушением репродуктивной функции: дис. ...д-ра мед. наук: 14.01.01/Шуршалина Анна Владимировна. - М., 2007. - 280 с.

295. Шуршалина АВ. Роль хронического эндометрита в развитии патологии репродуктивной функции. Российский медицинский журнал. 2007; (4):25-7.

296. Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod [Internet]. 2015; 30(2):323-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385744.

297. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil Steril [Internet]. 2004; 82(4):799-804. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15482749.

298. Сухих Г, Шуршалина А. Хронический эндометрит. ГЭОТАР-Мед. Москва; 2010.

299. Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner's syndrome: an analysis of the factors affecting the outcome. Hum Reprod [Internet]. 1997; 12(2):279-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9070711.

300. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner's syndrome and fertility: current status and possible putative prospects. Hum Reprod Update [Internet]. 7(6):603-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11727869.

301. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev [Internet]. 2012; 9 Suppl 2:713-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22946282.

302. SWYER GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J [Internet]. 1955; 2(4941):709-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13250193.

303. Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod [Internet]. 2013; 28(6):1598-609. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539610.

304. Practice Committee of American Society For Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril [Internet]. 2012; 97(2):282-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22192347.

305. Creatsas G, Deligeoroglou E, Tsimaris P, Pantos K, Kreatsa M. Successful pregnancy in a Swyer syndrome patient with preexisting hypertension. Fertil Steril [Internet]. 2011; 96(2):e83-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21782051.

306. Morcel K, Camborieux L, Programme de Recherches sur les Aplasies , Guerrier D. (MRKH) syndrome. Orphanet J Rare Dis [Internet]. 2007; 2:13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17359527.

307. MORRIS JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol [Internet]. 1953; 65(6):1192-211. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13057950.

308. Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol [Internet]. 2018; 131(1):e35-e42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266078.

309. Raziel A, Friedler S, Gidoni Y, Ben Ami I, Strassburger D, Ron-El R. Surrogate in vitro fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome. Hum Reprod [Internet]. 2012; 27(1):126-30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22052385.

310. Wood EG, Batzer FR, Corson SL. Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis. Hum Reprod [Internet]. 1999; 14(5):1178-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10325257.

311. Reichman DE, Laufer MR. syndrome: fertility counseling and treatment. Fertil Steril [Internet]. 2010; 94(5):1941-3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172513.

312. Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril [Internet]. 2009; 91(5):1886-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18439594.

313. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol [Internet]. 2011; 38(4):371-82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21830244.

314. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update [Internet]. 7(2):161-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11284660.

315. Letterie GS. Management of congenital uterine abnormalities. Reprod Biomed Online [Internet]. 2011; 23(1):40-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21652266.

316. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril [Internet]. 2016; 106(3):530-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27235766.

317. Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis ВС, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod Biomed Online [Internet]. 2014; 29(6):665-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444500.

318. Dicker D, Ashkenazi J, Dekel A, Orvieto R, Feldberg D, Yeshaya A, et al. The value of hysteroscopic evaluation in patients with preclinical in-vitro fertilization abortions. Hum Reprod [Internet]. 1996; 11(4):730-1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671317.

319. Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol [Internet]. 1996; 68(1-2):29-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8886677.

320. Brucker S, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of Congenital Malformations. Semin Reprod Med. 2011 Mar; 29(02): 101-12.

321. Revel A. Defective endometrial receptivity. Fertil Steril [Internet]. 2012; 97(5):1028-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22542142.

322. Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS [Internet]. 2000; 14(14):2093-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061649.

323. Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, et al. Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol [Internet]. 2013; 208(5):402.e1-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395921.

324. Steenvoorden MMC, Cornelissen M, van Leeuwen E, Schuurman NM, Egberink HF, Berkhout B, et al. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely. Fertil Steril [Internet]. 2012; 98(1):173-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22584022.

325. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril [Internet]. 2004; 81(6): 1542-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15193474.

326. Janssens RM, Lambalk CB, Schats R, Schoemaker J. Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: case report. Hum Reprod [Internet]. 1999; 14(10):2497-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10527976.

327. Pelinck MJ, Hoek A, Simons AHM, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update [Internet]. 8(2):129-39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12099628.

328. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod [Internet]. 2001; 16(2):259-62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11157816.

329. Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online [Internet]. 2007; 15(2):149-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489.

330. Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet]. 2011; 96(5):1066-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050.

331. Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet]. 2017; 108(4):572-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551.

332. Shaulov T, MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod Genet [Internet]. 2015; 32(7):1043-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26041679.

333. C, Olivennes F, Righini C, Fanchin R, J, Hamamah S, et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod [Internet]. 1999; 14(3):683-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10221695.

334. Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013; (8):CD010550.

335. Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed Online [Internet]. 2018; 36(1):94-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29111312.

336. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril [Internet]. 2013; 99(3):663-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23391409.

337. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online [Internet]. 2010; 21(4):566-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957.

338. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet]. 2014; 41(2):41-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627.

339. Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to "oocyte maturation abnormalities". Fertil Steril [Internet]. 2010; 94(2):496-501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589517.

340. Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003; 32(3 Pt 2):S52-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921.

341. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009; 19(3):343-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479.

342. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000; 15(1):165-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207.

343. Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod [Internet]. 2008; 23(12):2680-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885.

344. Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009; 92(3):907-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750.

345. Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007; 110(4):885-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024.

346. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012; 27(12):3601-8.

347. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May; 99(6):1476-84.

348. Coyne K, Purdy M, K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front Public Heal [Internet]. 2014; 2. Available from: http://journal.frontiersin.org/article/10.3389/fpubh.2014.00246/abstract.

349. Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet [Internet]. 2014; 31(7):927-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484.

350. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet]. 2012; 97(5):1039-43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086.

351. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by "recurrent implantation failure"? A systematic review and opinion. Reprod Biomed Online [Internet]. 2014; 28(4):409-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24581986.

352. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online [Internet]. 2014; 28(1):14-38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24269084.

353. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2013 г. Проблемы репродукции. 2015; 21(6):16-32.

354. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2014 г. Проблемы репродукции. 2016; 22(5):8-21.

355. European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, de Geyter C, Kupka MS, de Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Hum Reprod. 2016; 31(8):1638-52.

356. Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril [Internet]. 1987; 48(6):1051-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3678505.

357. Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol [Internet]. 1986; 155(3):480-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3752170.

358. Chauhan M, Barratt CL, Cooke SM, Cooke ID. Differences in the fertility of donor insemination recipients-a study to provide prognostic guidelines as to its success and outcome. Fertil Steril [Internet]. 1989; 51(5):815-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2707456.

359. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update [Internet]. 15(3):265-77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240042.

360. Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review. Hum Reprod [Internet]. 2003; 18(5):941-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12721166.

361. Green KA, Zolton JR, Schermerhorn SM V, Lewis TD, Healy MW, Terry N, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril [Internet]. 2017; 107(4):924-933.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28238492.

---